AbbVie Newsroom

Raymond James Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $218

Futu NewsJan 28 23:32

BofA Securities Maintains AbbVie(ABBV.US) With Hold Rating, Maintains Target Price $191

Futu NewsJan 28 21:31

Citi Maintains AbbVie(ABBV.US) With Buy Rating, Announces Target Price $205

Futu NewsJan 28 20:35

AbbVie Is Maintained at Buy by Citigroup

Dow JonesJan 28 20:24

AbbVie Analyst Ratings

BenzingaJan 28 20:13

Goldman Sachs Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $208

Futu NewsJan 28 01:31

Piper Sandler Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $227

Futu NewsJan 27 20:31

Piper Sandler Sticks to Its Buy Rating for AbbVie (ABBV)

TipRanksJan 27 20:02

Piper Sandler Adjusts Price Target on AbbVie to $227 From $220, Keeps Overweight Rating

MT NewswiresJan 27 18:57

Goldman Sachs Adjusts Price Target on AbbVie to $208 From $205, Keeps Buy Rating

MT NewswiresJan 27 18:57

Morgan Stanley Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $224

Futu NewsJan 24 21:31

AbbVie (ABBV) Receives a Buy From Morgan Stanley

TipRanksJan 24 21:20

Analysts Are Bullish on These Healthcare Stocks: AbbVie (ABBV), Johnson & Johnson (JNJ)

TipRanksJan 23 19:31

Wells Fargo Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $195

Futu NewsJan 23 19:31

Berenberg Bank Sticks to Its Hold Rating for AbbVie (ABBV)

TipRanksJan 22 14:30

Guggenheim Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $212

Futu NewsJan 17 20:32

Redburn Atlantic Adjusts Price Target on AbbVie to $216 From $214, Maintains Buy Rating

MT NewswiresJan 17 19:39

MoonLake Upgraded at Goldman Sachs on Promise of Hidradenitis Suppurativa Asset

Seeking AlphaJan 17 06:24

BMO Capital Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $208

Futu NewsJan 17 05:31

Redburn Atlantic Adjusts Price Target on AbbVie to $214 From $216, Keeps Buy Rating

MT NewswiresJan 11 01:32